-+ 0.00%
-+ 0.00%
-+ 0.00%

BLACK DIAMOND THERAPEUTICS - ANNOUNCES POSITIVE PHASE 2 SILEVERTINIB RESULTS AND FDA FEEDBACK FOR 1L EGFR-NCM NSCLC - SEC FILING

Reuters·11/10/2026 11:31:03